Medicamen Organics IPO Allotment Status Online

Medicamen Organics IPO Allotment Status Online

Medicamen Organics IPO Allotment Status Online : Medicamen Organics IPO is Open on June 21, 2024 and Close on June 25, 2024. Medicamen Organics IPO to Raise 3,100,000 shares (Approx ₹10.54 Cr) via IPO. The Fresh Issue of 3,100,000 shares (Approx ₹10.54 Cr).

  • The Retail Quota Is 35%
  • QIB Is 50%
  • HNI Is 15%.

Medicamen Organics IPO Basis of Allotment Status on 26 June, 2024. Medicamen Organics IPO Refund Date is 27 June 2024 and Medicamen Organics IPO Credit to Demat on 27 June 2024.

Also Read: Medicamen Organics IPO details IPO Date, Price, GMP, Review, Details

Medicamen Organics IPO Allotment Link Online

About –

Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.

We market our product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis. We have a track record of operating B2B model which covers contract manufacturing model.

Our products are marketed across India as well as African, CIS and south East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by our third-party distributor. we have entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.


1. Capsules: – Various capsule formulation/compositions are being manufactured by us including but not limited to the following:-

  •  Rabeprazole and Domperidone to treat with Hyperacidity.
  •  Tacrolimus Capsule belongs to a class of drugs known as immunosuppressants.
  •  Ribavirin capsules is an antiviral medicine that is used in the treatment of chronic hepatitis C virus (HCV) infection. It prevents the multiplication of virus in human cells and clears up the infection.

2. Ointment/External Preparation: – We are producing antifungal/anti-bacterial formulations like Miconazole, Nystatin, Clotrimazole, Nadifloxacin, Mometasone in single as well as a composition form like cream and Gel. Topical Diclofenac, Salicylic acid composition are also being manufactured.

3. Suspension: – A variety of cough syrups, Multivitamin/Minerals, Calcium supplements, Antacid liquids, Iron supplements, Laxative liquids, Anthelmetic suspensions, anti-pyritic and anti-inflammatory suspensions are our key products.

4. Dry Powder Sachet:- We are manufacturing sachets like pre and probiotic in granular form. Diclofenac Potassium and Sodium granules for oral administration.

5. Tablet: – (also known as a pill): We are producing various composition of Ferrous and Folic Acid tablets. These tablets are widely used as an iron supplement to treat or prevent low blood levels of iron (such as those caused by anemia or pregnancy). Iron being an important mineral that the body needs to produce red blood cells keeps, an individual in good health. The formulation is developed in a manner to fulfil the deficiency quickly.

Leave a Comment